Current Report Filing (8-k)
May 16 2022 - 12:23PM
Edgar (US Regulatory)
0001543623
false
0001543623
2022-05-16
2022-05-16
0001543623
dei:FormerAddressMember
2022-05-16
2022-05-16
iso4217:USD
xbrli:shares
iso4217:USD
xbrli:shares
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 8-K
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(D) OF THE
SECURITIES EXCHANGE ACT OF 1934
DATE OF REPORT: May
16, 2022
US Nuclear Corp.
(EXACT NAME OF REGISTRANT AS SPECIFIED IN CHARTER)
Delaware |
|
000-54617 |
|
45-4535739 |
(STATE OR OTHER JURISDICTION OF
INCORPORATION OR
ORGANIZATION) |
|
(COMMISSION FILE NO.) |
|
(IRS EMPLOYEE IDENTIFICATION NO.) |
7051 Eton Avenue
Canoga Park, CA 91303
(ADDRESS OF PRINCIPAL EXECUTIVE OFFICES)
(818) 883-7043
(ISSUER TELEPHONE NUMBER)
N/A
(FORMER NAME OR FORMER ADDRESS, IF CHANGED SINCE
LAST REPORT)
Check the appropriate box below if the Form 8-K filing
is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General
Instruction A.2. below):
|
|
☐ |
Written communication pursuant to Rule 425 under the Securities Act (17 CFR 230.425) |
|
|
☐ |
Soliciting Material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) |
|
|
☐ |
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) |
|
|
☐ |
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |
Indicate by check mark whether the registrant
is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the
Securities Exchange Act of 1934 (§240.12b-2 of this chapter. ☒
If an emerging growth company, indicate by check
mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting
standards provided pursuant to Section 13(a) of the Exchange Act.
SECTION 1 – REGISTRANT'S BUSINESS AND OPERATIONS
Item 1.01 Entry into a Material Definitive Agreement
On May 5, 2022, US Nuclear
Corp., a Delaware corporation (the “Corporation”) closed on a Securities Purchase Agreement (the “SPA”) with Mast
Hill Fund, L.P., providing for the issuance of the promissory note in the principal amount of $750,000.00, convertible into shares of
the common stock at a fixed price of $0.20 per share, and cash warrants with $0.75 strike price. US Nuclear Corp. receives $611,000 in
net working capital to increase revenue by improving operations, upgrade best-selling products and develop new products, and expand sales
and marketing in high growth markets. The SPA was authorized by consent resolution of the Board of Directors as being in the best interests
of the Corporation. The reader is directed to Item 9.01 (d) for review of the SPA, promissory note, and common stock purchase warrant.
SECTION 9 – FINANCIAL STATEMENTS AND EXHIBITS
Item 9.01 Financial Statement and Exhibits.
(d) Exhibits:
SIGNATURES
Pursuant to the requirements of the Securities
Exchange Act of 1934, the Registrant has duly caused this Report to be signed on its behalf by the undersigned hereunto duly authorized.
|
U.S. Nuclear, Inc. |
|
|
|
|
By: |
/s/ Robert Goldstein |
|
|
Name: Robert Goldstein |
|
|
Title: Chief Executive Officer and President |
|
|
|
|
|
Dated: May 16, 2022 |
|
2
US Nuclear (PK) (USOTC:UCLE)
Historical Stock Chart
From Dec 2024 to Jan 2025
US Nuclear (PK) (USOTC:UCLE)
Historical Stock Chart
From Jan 2024 to Jan 2025